Viemed Healthcare Inc. (VMD)
Viemed Healthcare Statistics
Share Statistics
Viemed Healthcare has 39.52M shares outstanding. The number of shares has increased by 1.16% in one year.
Shares Outstanding | 39.52M |
Shares Change (YoY) | 1.16% |
Shares Change (QoQ) | 0.29% |
Owned by Institutions (%) | 64.56% |
Shares Floating | 34.29M |
Failed to Deliver (FTD) Shares | 3 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 365.09K, so 0.94% of the outstanding shares have been sold short.
Short Interest | 365.09K |
Short % of Shares Out | 0.94% |
Short % of Float | 1.08% |
Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is 27.59 and the forward PE ratio is 23.14. Viemed Healthcare's PEG ratio is 3.72.
PE Ratio | 27.59 |
Forward PE | 23.14 |
PS Ratio | 1.39 |
Forward PS | 0.9 |
PB Ratio | 2.37 |
P/FCF Ratio | 235.82 |
PEG Ratio | 3.72 |
Enterprise Valuation
Viemed Healthcare Inc. has an Enterprise Value (EV) of 298.58M.
EV / Earnings | 26.5 |
EV / Sales | 1.33 |
EV / EBITDA | 17.84 |
EV / EBIT | 16.68 |
EV / FCF | 226.54 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.05.
Current Ratio | 1.42 |
Quick Ratio | 1.3 |
Debt / Equity | 0.05 |
Total Debt / Capitalization | 4.97 |
Cash Flow / Debt | 5.69 |
Interest Coverage | 23.07 |
Financial Efficiency
Return on equity (ROE) is 0.09% and return on capital (ROIC) is 9.01%.
Return on Equity (ROE) | 0.09% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 9.01% |
Revenue Per Employee | $190,209.5 |
Profits Per Employee | $9,554.71 |
Employee Count | 1,179 |
Asset Turnover | 1.27 |
Inventory Turnover | 21.08 |
Taxes
Income Tax | 4.76M |
Effective Tax Rate | 0.29 |
Stock Price Statistics
The stock price has increased by -23.01% in the last 52 weeks. The beta is 1.51, so Viemed Healthcare's price volatility has been higher than the market average.
Beta | 1.51 |
52-Week Price Change | -23.01% |
50-Day Moving Average | 7.83 |
200-Day Moving Average | 7.82 |
Relative Strength Index (RSI) | 39.41 |
Average Volume (20 Days) | 111.98K |
Income Statement
In the last 12 months, Viemed Healthcare had revenue of 224.26M and earned 11.27M in profits. Earnings per share was 0.29.
Revenue | 224.26M |
Gross Profit | 133.2M |
Operating Income | 17.9M |
Net Income | 11.27M |
EBITDA | 16.73M |
EBIT | 17.9M |
Earnings Per Share (EPS) | 0.29 |
Balance Sheet
The company has 17.54M in cash and 6.87M in debt, giving a net cash position of 10.67M.
Cash & Cash Equivalents | 17.54M |
Total Debt | 6.87M |
Net Cash | 10.67M |
Retained Earnings | 89.69M |
Total Assets | 177.07M |
Working Capital | 15.55M |
Cash Flow
In the last 12 months, operating cash flow was 39.09M and capital expenditures -37.77M, giving a free cash flow of 1.32M.
Operating Cash Flow | 39.09M |
Capital Expenditures | -37.77M |
Free Cash Flow | 1.32M |
FCF Per Share | 0.03 |
Margins
Gross margin is 59.4%, with operating and profit margins of 7.98% and 5.02%.
Gross Margin | 59.4% |
Operating Margin | 7.98% |
Pretax Margin | 7.21% |
Profit Margin | 5.02% |
EBITDA Margin | 7.46% |
EBIT Margin | 7.98% |
FCF Margin | 0.59% |
Dividends & Yields
VMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 3.99% |
FCF Yield | 0.46% |
Analyst Forecast
Currently there are no analyst rating for VMD.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 6.36 |
Piotroski F-Score | 7 |